Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
grade D 7.65 -2.55% -0.20
CVM closed down 2.55 percent on Monday, October 21, 2019, on 1.56 times normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical CVM trend table...

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -2.55%
MACD Bearish Centerline Cross Bearish -2.55%
Bollinger Band Squeeze Range Contraction -2.55%

Older signals for CVM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.
Medicine Cancer Medical Specialties Immunology Immunotherapy Immune System Rheumatoid Arthritis Vaccination Autoimmunity Transplantation Vaccine Head And Neck Cancer Allergies Treatment Of Head And Neck Cancer
Is CVM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 9.93
52 Week Low 2.37
Average Volume 741,341
200-Day Moving Average 5.8635
50-Day Moving Average 8.2316
20-Day Moving Average 8.573
10-Day Moving Average 8.179
Average True Range 0.603
ADX 23.91
+DI 20.0839
-DI 27.2894
Chandelier Exit (Long, 3 ATRs ) 8.121
Chandelier Exit (Short, 3 ATRs ) 8.869
Upper Bollinger Band 9.5448
Lower Bollinger Band 7.6012
Percent B (%b) 0.03
BandWidth 22.671177
MACD Line -0.0818
MACD Signal Line 0.0512
MACD Histogram -0.133
Fundamentals Value
Market Cap 71.4 Million
Num Shares 9.33 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -4.97
Price-to-Sales 102.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.97
Resistance 3 (R3) 8.92 8.43 8.75
Resistance 2 (R2) 8.43 8.09 8.45 8.67
Resistance 1 (R1) 8.04 7.88 7.79 8.09 8.60
Pivot Point 7.55 7.55 7.43 7.57 7.55
Support 1 (S1) 7.16 7.21 6.92 7.21 6.70
Support 2 (S2) 6.67 7.01 6.70 6.63
Support 3 (S3) 6.28 6.67 6.55
Support 4 (S4) 6.33